All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
7E11062

Cancer Genomics of the Kidney

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

  • Call for proposals

    FP7-Health-2009-two-stage

  • Main participants

  • Contest type

    RP - Co-financing of EC programme

  • Contract ID

    MSMT-1839/2013-310

Alternative language

  • Project name in Czech

    Cancer Genomics of the Kidney

  • Annotation in Czech

    The International Cancer Genome Consortium (ICGC) has the goal of obtaining a comprehensive description of genomic, transcriptomic and epigenomic changes in 50 different tumour types and/or subtypes, with the aim of elucidating the genomic changes present in the many forms of cancers that contribute to the burden of disease throughout the world. Here, we present a proposal for a European contribution to this effort through application of state-of-the-art approaches to the genomic analysis of clear cellrenal carcinoma. This cancer is of particular interest within Europe, as the highest global incidence rates are observed in areas of Central Europe. Kidney cancer incidence has increased over the last two decades, and it is now the 8th most common cancerin the EU. CAGEKID brings clinical and epidemiological resources together with the necessary genetics and genomics expertise across Europe required for this effort. In the first phase of the study, 50 matched pairs of DNA extracted from the tumour and constitutional DNA will be completely sequenced, and brought together with information from whole genome transcript analysis and DNA methylation analysis from tumoural and peritumoural tissue. In the second phase, 450 additional sample pairs will be analysed in a targeted manner. The results from this part of the study will be used to relay the acquired information to targeted protein analyses. The primary data will be made available to the scientific community, and the programme will contribute to establishing norms for the manipulation and protein analyses. The primary data will be made available to the scientific community, and the programme will contribute to establishing norms for the manipulation and storage of biological samples. CAGEKID will provide the first systematic analysis of this tumour site , and it will give new insights into disease aetiology with application for diagnosis and treatment.

Scientific branches

  • R&D category

    AP - Applied research

  • CEP classification - main branch

    FD - Oncology and haematology

  • CEP - secondary branch

  • CEP - another secondary branch

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    30204 - Oncology<br>30205 - Hematology

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    Following the condition that the candidate of financial contribution was evaluated and afterwards selected by international provider in accordance with the rules of the program the Ministry of Education, Youth ans Sports does not realize the evaluation of project results. The project is evaluated only after its approval by an international provider.

Solution timeline

  • Realization period - beginning

    Jan 1, 2011

  • Realization period - end

    Feb 28, 2014

  • Project status

    U - Finished project

  • Latest support payment

    Mar 20, 2014

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP15-MSM-7E-U/01:1

  • Data delivery date

    Jul 2, 2015

Finance

  • Total approved costs

    1,215 thou. CZK

  • Public financial support

    1,215 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK